With over a decade of operation, this CTD dossier owner and manufacturer focuses on expanding its manufacturing capabilities and celebrating milestones. It has recently upgraded its facilities with new equipment and is preparing for its 2024 Annual General Meeting (AGM). The company emphasizes its commitment to shareholder engagement and recent developments, including the induction of new team members and a major anniversary celebration. Their product range and specific therapeutic areas were not detailed, but the emphasis on operational advancements and shareholder communication highlights their dedication to growth and industry presence.

This pharmaceutical company specializes in developing and manufacturing a range of healthcare products. Their portfolio includes prescription medications, over-the-counter drugs, medical devices, and dietary supplements, targeting key therapeutic areas like cardiovascular health, pain management, respiratory conditions, and gastrointestinal disorders. They primarily produce oral dosage forms, such as tablets, capsules, and liquids. The company holds GMP certifications, ensuring adherence to high manufacturing standards. Their commitment to innovation is demonstrated through several product patents protecting their unique formulations. They operate across multiple regions including North America and the EU, supplying a global market with their diverse range of healthcare solutions.

Established in 1976, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 40 countries and regions. With a dedicated team of approximately 1,000 employees, it operates GMP-certified facilities in Vietnam, producing a diverse range of products including tablets, capsules, creams, balms, external liquids, and powder sachets. As a GMP manufacturer, it holds certifications such as cGMP and ISO 9001:2000, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​